Internal Medicine, Nephrology · Plymouth, MA
NPI
1386691012
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
47 Obery Street, Suite 1a
Plymouth, MA, 02360
Phone (508) 747-4883
Groups this clinician bills Medicare through
Medicare paid, 2024
$498K
6,420 services
Medicare patients, 2024
1,215
Average age 76
Drug cost, 2024
$2.1M
17,893 prescriptions
Company payments, 2025
$37.2
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Piotr Lazowski was code 99214 (office e&m - established), 1,771 times for 765 patients. In total Piotr Lazowski billed 6,420 services in 49 codes, and Medicare paid $498K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,771 | 765 | $89.27 | $158K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 1,500 | 12 | $5.74 | $8,615 |
| 90960 ESRD Related Services (not dialysis) | Office | 425 | 98 | $270.21 | $115K |
| 99232 Hospital E&M - Subsequent | Facility | 327 | 137 | $61.26 | $20K |
| 99223 Hospital E&M - Initial | Facility | 321 | 254 | $130.63 | $42K |
| 99308 SNF E&M | Office | 291 | 125 | $51.86 | $15K |
| 99309 SNF E&M | Office | 189 | 62 | $85.33 | $16K |
| 85018 Blood Count | Office | 170 | 23 | $2.32 | $394 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 164 | 164 | $131.16 | $22K |
| 90935 Hemodialysis | Facility | 163 | 58 | $55.76 | $9,088 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 143 | 143 | $19.11 | $2,733 |
| 96372 Injection Administration | Office | 138 | 22 | $11.02 | $1,521 |
| 99233 Hospital E&M - Subsequent | Facility | 110 | 46 | $93.22 | $10K |
| 90961 ESRD Related Services (not dialysis) | Office | 100 | 61 | $228.17 | $23K |
| 99211 Office E&M - Established | Office | 75 | 19 | $17.56 | $1,317 |
By year: 2022 $512K for 7,386 services; 2023 $567K for 7,767 services; 2024 $498K for 6,420 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 170 | 23 | $2.32 | $394 |
Medicare prescription drug claims, 2024
In 2024, the drug Piotr Lazowski prescribed most often to Medicare patients was Calcitriol, with 686 prescriptions and refills. In total Piotr Lazowski wrote 17,893 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 686 | 1,817 | 197 | $20K |
| Atorvastatin Calcium Generic | 676 | 1,054 | 150 | $11K |
| Losartan Potassium Generic | 589 | 1,517 | 181 | $7,895 |
| Lisinopril Generic | 581 | 1,173 | 140 | $5,436 |
| Furosemide Generic | 546 | 905 | 124 | $3,323 |
| Spironolactone Generic | 519 | 1,304 | 139 | $5,103 |
| Trazodone Hcl Generic | 446 | 483 | 71 | $7,247 |
| Amlodipine Besylate Generic | 430 | 778 | 97 | $3,905 |
| Eliquis Apixaban | 425 | 472 | 40 | $160K |
| Nifedipine Er Nifedipine | 396 | 859 | 109 | $16K |
| Hydrochlorothiazide Generic | 382 | 931 | 102 | $1,121 |
| Metoprolol Succinate Generic | 372 | 617 | 85 | $7,362 |
| Pantoprazole Sodium Generic | 369 | 471 | 65 | $13K |
| Gabapentin Generic | 367 | 402 | 54 | $7,238 |
| Farxiga Dapagliflozin Propanediol | 332 | 628 | 111 | $343K |
Brand drugs: 3,001 claims; generic drugs: 14,812 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Piotr Lazowski $37.2 ($37.2 in general payments such as food, travel and fees) from 2 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $34.04.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.